Acurx Pharmaceuticals (ACXP US)

Analysis

Health Care • United States

Acurx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a new class of antibiotics for infections caused by bacteria. Acurx Pharmaceuticals serves customers worldwide.

Refresh

Exchange Announcement • 09 Sep 2026 04:27

S-1 | IPO Registration

Exchange Announcement • 14 Aug 2026 04:07

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 13 May 2026 03:05

424B3 | Prospectus

Exchange Announcement • 13 May 2026 03:04

424B3 | Prospectus

Exchange Announcement • 12 May 2026 04:05

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

S-1 | IPO Registration

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

424B3 | Prospectus

424B3 | Prospectus

Quarterly Report (Form 10-Q | Period ending 2026-03-31)